GSK plc (NYSE:GSK) confirmed the sale of 385.3 million shares in Haleon plc (NYSE:HLN) for $1.58 billion. The shares represented around 4.2% of the issued share capital of Haleon. Following the ...

GlaxoSmithKline has introduced a new toothpaste delivery system that disperses active ingredients quickly, penetrating hard-to-reach areas of the mouth, according to the company. Iso-active, which is ...

London-based consumer healthcare group Haleon Plc (NYSE:HLN) stock is trading lower on Thursday. Haleon, GSK Plc’s (NYSE:GSK) spun off, reported revenue of 11.23 billion pounds (US$14.19 billion) for ...

GSK Plc will sell its remaining stake in Haleon Plc for £1.25 billion ($1.6 billion), completing the drugmaker’s separation from the consumer health company. About 385 million shares will be sold at a ...

A Reuters report regarding the rejection of Unilever's $68 billion offer for GlaxoSmithKline’s consumer healthcare assets is raising questions, including whether Unilever should raise the bid and risk ...

LONDON (Reuters Breakingviews) - GlaxoSmithKline’s personal health spinoff is beginning life with a target on its back. Haleon, maker of Advil painkillers and Sensodyne toothpaste, will next month ...